Duo-Vil (amitriptyline / perphenazine) Drug Interactions
A total of 693 drugs are known to interact with Duo-Vil (amitriptyline / perphenazine).
- 133 major drug interactions
- 524 moderate drug interactions
- 36 minor drug interactions
Check for interactions
Most frequently checked interactions
View interaction reports for Duo-Vil (amitriptyline / perphenazine) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- CoQ10 (ubiquinone)
- Coreg (carvedilol)
- Effexor (venlafaxine)
- Focalin XR (dexmethylphenidate)
- Lexapro (escitalopram)
- Methylin (methylphenidate)
- Paxil (paroxetine)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Strattera (atomoxetine)
- Xanax (alprazolam)
- Zyrtec (cetirizine)
Duo-Vil (amitriptyline / perphenazine) alcohol/food interactions
There is 1 alcohol/food interaction with Duo-Vil (amitriptyline / perphenazine)
Duo-Vil (amitriptyline / perphenazine) disease interactions
There are 37 disease interactions with Duo-Vil (amitriptyline / perphenazine) which include:
- dementia
- liver damage
- acute alcohol intoxication
- cardiovascular disease
- CNS depression
- head injury
- anticholinergic effects
- cardiovascular disease
- pheochromocytoma
- acute myocardial infarction recovery
- cardiovascular disease
- depression
- seizure disorders
- anticholinergic effects
- breast cancer
- dystonic reactions
- hematologic toxicity
- NMS
- parkinsonism
- renal dysfunction
- respiratory disorders
- seizure disorders
- tardive dyskinesia
- bone marrow suppression
- diabetes
- renal/liver disease
- schizophrenia/bipolar disorder
- tardive dyskinesia
- acute alcohol intoxication
- bipolar disorder screening
- glaucoma
- hyper/hypoglycemia
- liver/renal disease
- neutropenia
- schizophrenia
- thyroid disorders
- urinary retention
More about Duo-Vil (amitriptyline / perphenazine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug class: psychotherapeutic combinations
- FDA Alerts (1)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
